AFP – India’s top court is set to rule Monday on a patent challenge by Swiss pharmaceutical giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in poor nations. Generic drug firms in India — long known as the “pharmacy to the developing world” —…
Swiss and Canadian health authorities on Wednesday lifted a ban on sales of flu vaccines made by Swiss pharmaceutical giant Novartis after determining they were safe and efficient. “The partially visible white particles are in no way external impurities, but are agglutinations of ordinary protein components of the vaccine,” Switzerland’s…
WASHINGTON (Reuters) – Regulators will ask outside experts if the higher of two proposed doses of a Novartis AG drug is needed to treat chronic obstructive pulmonary disease, documents released on Friday said. A key question for outside advisers who meet next week is “whether the second higher dose of…